NEXTCURE, INC Stock Split Ratio
NEXTCURE, INC (NXTC) reported Stock Split Ratio of 8.00% for the 12-month period ending 2025-12-31, per its S-4 filed 2026-08-18.
Financial Statements › Notes
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2026-08-18
- NEXTCURE, INC stockholders' equity note, stock split, conversion ratio for the quarter ending 2025-09-30 was 8.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 3 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|---|---|
| 2025-12-31 | 8.00% S-4 · filed 2026-08-18 | ||
| 2025-09-30 | 8.00% 10-Q · filed 2025-11-05 | ||
| 2025-07-14 | 8.00% S-4 · filed 2026-08-18 | ||
| 2019-05-03 | 12.45% 10-K · filed 2025-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |